Twist Bioscience (TWST) Income towards Parent Company (2017 - 2026)
Twist Bioscience (TWST) posted quarterly Income towards Parent Company of -$44.0 million for Q1 2026, down 11.93% year-over-year from -$50.0 million in Q1 2025, and down 44.3% quarter-over-quarter from -$30.5 million in Q4 2025.
Twist Bioscience (TWST) Income towards Parent Company (2017 - 2026) Analysis & Trends
Twist Bioscience (TWST) has reported Income towards Parent Company for 10 consecutive years, with -$44.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Income towards Parent Company fell 11.93% year-over-year to -$44.0 million; the TTM figure through Mar 2026 stood at -$81.2 million (up 57.5% YoY), while the FY2025 annual figure was -$77.7 million, up 62.79% from the prior year.
- Income towards Parent Company eased to -$44.0 million in Q1 2026 per TWST's latest filing, from -$30.5 million in the prior quarter.
- Across five years, Income towards Parent Company topped out at $20.4 million in Q2 2025 and bottomed at -$85.6 million in Q2 2024.
- Historically, Income towards Parent Company has averaged -$43.4 million across 5 years, with a median of -$44.0 million in 2026.
- Annual changes were most pronounced in 2022 — Income towards Parent Company plunged 59.99% — and 2025, when it soared 123.82%.
- Twist Bioscience's Income towards Parent Company stood at -$41.8 million in 2022, then declined by 2.78% to -$43.0 million in 2023, then climbed by 26.5% to -$31.6 million in 2024, then climbed by 3.45% to -$30.5 million in 2025, then slumped by 44.3% to -$44.0 million in 2026.
- Business Quant data shows TWST's Income towards Parent Company at -$44.0 million in Q1 2026, -$30.5 million in Q4 2025, and -$27.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Twist Bioscience | 7.18 Bn | 7.02 Bn | 62.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -35.05 Mn |
| Mar 31, 2026 | -44.02 Mn |
| Dec 31, 2025 | -30.51 Mn |
| Sep 30, 2025 | -27.10 Mn |
| Jun 30, 2025 | 20.38 Mn |
| Mar 31, 2025 | -39.33 Mn |
| Dec 31, 2024 | -31.60 Mn |
| Sep 30, 2024 | -34.66 Mn |
| Jun 30, 2024 | -85.57 Mn |
| Mar 31, 2024 | -45.45 Mn |
| Dec 31, 2023 | -42.99 Mn |
| Sep 30, 2023 | -46.29 Mn |
| Jun 30, 2023 | -57.40 Mn |
| Mar 31, 2023 | -59.18 Mn |
| Dec 31, 2022 | -41.82 Mn |
| Sep 30, 2022 | -51.13 Mn |
| Jun 30, 2022 | -60.52 Mn |
| Mar 31, 2022 | -60.67 Mn |
| Dec 31, 2021 | -45.56 Mn |
| Sep 30, 2021 | -41.24 Mn |